Receive The Newest Study Notifications

Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial

by Lance Smith | Oct 10, 2019 | Study Scavenger Clinical Trial Recruitment Platform

Median overall survival for ADXS-PSA in combination with KEYTRUDA® increased to 33.6 months from previously reported 21.1 months PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery,...

Innovation Pharmaceuticals Clinical Trial of Oral Brilacidin in Ulcerative Colitis Program Expected to Commence in December; Top-Line Data in Q1 2020

by Lance Smith | Oct 3, 2019 | Study Scavenger Clinical Trial Recruitment Platform

BEVERLY, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that management is finalizing documentation necessary to initiate the planned Phase...

Zydus Announces Positive Results From EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NAFLD and NASH

by Lance Smith | Oct 3, 2019 | Study Scavenger Clinical Trial Recruitment Platform

– EVIDENCES IV trial meets primary efficacy end-points – Statistically significant 44.39 % reduction in ALT (alanine aminotransferase) observed with Saroglitazar Magnesium treated patients AHMEDABAD, India, Oct. 3, 2019 /PRNewswire/ — Zydus Cadila,...

Theragnostics Reports Positive Clinical Trial Results from Prostate Cancer Study

by Lance Smith | Oct 3, 2019 | Study Scavenger Clinical Trial Recruitment Platform

Study evaluates clinical utility of 68Ga THP-PSMA PET/CT imaging in men with newly diagnosed and recurrent prostate cancer LONDON and BOSTON, Oct. 2, 2019 /PRNewswire/ — Theragnostics, which is developing innovative radiopharmaceuticals to improve cancer...

Spero Therapeutics Announces Positive Recommendation to Continue Phase 3 Clinical Trial of SPR994 as Planned Following Independent Review Committee Analysis of SPR994 Treated Patients in Lead-in Cohort of Trial

by Lance Smith | Oct 3, 2019 | Study Scavenger Clinical Trial Recruitment Platform

CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant...

Athira Pharma Announces Completion of Phase 1b Clinical Trial of NDX-1017 in Alzheimer’s Patients

by Lance Smith | Oct 3, 2019 | Study Scavenger Clinical Trial Recruitment Platform

— Data to be Featured in Oral Presentation at Clinical Trials on Alzheimer’s Disease SEATTLE, WA, USA I October 2, 2019 I Athira Pharma, Inc., a clinical-stage company dedicated to developing first-in-class therapies for Alzheimer’s and...